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induced diabetic rats 
 
ABSTRACT 
Type 2 diabetes is a chronic disease with growing public health concern globally. Finding 
remedies to assist this health issue requires recruiting appropriate animal model for 
experimental studies. This study was designated to evaluate metabolic and immunologic 
changes in streptozotocin-nicotinamide induced diabetic rats as a model of type 2 diabetes. 
Male rats were induced diabetes using nicotinamide (110 mg/kg) and streptozotocin (65 
mg/kg). Following 42 days, biochemical and immunological tests showed that diabetic rats 
had higher levels of blood glucose, WBC, certain abnormalities in lipid profile and 
insufficient mitogenic responses of lymphocytes (p < 0.05). However, the status of the total 
antioxidant, inflammatory biomarkers and other parameters of full blood count (except HCT) 
were not significantly altered. Phenotyping assay indicated insignificant lymphocyte subtype 
imbalances excluding a significant rise in the level of CD4+CD25+ marker (p < 0.05). This 
model of diabetic animals may represent some but not all symptoms of human type 2 diabetes. 
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